Recurrent Urinary Tract Infection in Women: Primary Care Referral Patterns in a Tertiary Care Center.
Adolescent
Adult
Aged
Anti-Bacterial Agents
/ therapeutic use
Female
Gynecological Examination
/ statistics & numerical data
Humans
Middle Aged
Practice Patterns, Physicians'
/ statistics & numerical data
Primary Health Care
Recurrence
Referral and Consultation
Retrospective Studies
Tertiary Care Centers
Urinalysis
/ statistics & numerical data
Urinary Tract Infections
/ epidemiology
Young Adult
Journal
Female pelvic medicine & reconstructive surgery
ISSN: 2154-4212
Titre abrégé: Female Pelvic Med Reconstr Surg
Pays: United States
ID NLM: 101528690
Informations de publication
Date de publication:
01 02 2021
01 02 2021
Historique:
pubmed:
12
7
2019
medline:
15
12
2021
entrez:
12
7
2019
Statut:
ppublish
Résumé
With more than 150 million urinary tract infections (UTIs) diagnosed globally per year, the impact on patient care is significant. We sought to examine appropriateness of management of recurrent UTI before referral to a female pelvic medicine and reconstructive surgery practice, as well as the characteristics of patients referred. The medical records of 100 consecutive women with a diagnosis of "recurrent UTI" at a single institution between November 2010 and December 2015 were reviewed. The baseline clinical characteristics, laboratory testing, and treatments before and at referral to the female pelvic medicine and reconstructive surgery were examined by descriptive statistics. The evaluation and treatment patterns for recurrent UTI before specialist referral varied widely. Pelvic examination was performed in only 20.8% of patients before referral. Although most women had at least 1 culture performed (65.2%), treatments were variable. Only 42.7% of patients received recommended first-line antibiotic therapy. At symptom recurrence, only 47.2% of patients received a urine culture; most were empirically treated. Approximately 35.0% of patients received the same antibiotic upon their first recurrence. A large proportion of patients referred for recurrent UTI to a specialty practice had no prior culture, physical examination, or symptom-specific evaluation before referral. Despite existing guidelines, the evaluation, treatment, and referral patterns for recurrent UTI are highly varied and rarely conform to recommendations. Further studies are needed to confirm these trends and determine interventions to improve the efficacy and efficiency of primary care for women with recurrent UTI.
Identifiants
pubmed: 31295184
pii: 01436319-202102000-00010
doi: 10.1097/SPV.0000000000000752
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
118-120Informations de copyright
Copyright © 2019 American Urogynecologic Society. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest and sources of funding: none declared.
Références
Kucheria R, Dasgupta P, Sacks SH, et al. Urinary tract infections: new insights into a common problem. Postgrad Med J 2005;81(952):83–86.
Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 2003;49(2):53–70.
Centers for Disease Control and Prevention. National Hospital Ambulatory Medical Care Survey: 2012 Emergency Department Summary Tables. US Department of Health and Human Services, 2012. Available at: https://www.cdc.gov/nchs/data/ahcd/nhamcs_emergency/2012_ed_web_tables.pdf. Accessed January 17, 2019.
Bent S, Nallamothu BK, Simel DL, et al. Does this woman have an acute uncomplicated urinary tract infection?JAMA 2002;287(20):2701–2710.
Brubaker L, Carberry C, Nardos R, et al. American Urogynecologic Society best-practice statement: recurrent urinary tract infection in adult women. Female Pelvic Med Reconstr Surg 2018;24(5):321–335.
Anger J, Lee U, Ackerman AL, et al. Recurrent uncomplicated urinary tract infections in women: AUA/CUA/SUFU guideline. J Urol 2019. [Epub ahead of print].
Wilbanks MD, Galbraith JW, Geisler WM. Dysuria in the emergency department: missed diagnosis of Chlamydia trachomatis. West J Emerg Med 2014;15(2):227–230.
Tomas ME, Getman D, Donskey CJ, et al. Overdiagnosis of urinary tract infection and underdiagnosis of sexually transmitted infection in adult women presenting to an emergency department. J Clin Microbiol 2015;53(8):2686–2692.
Palma F, Volpe A, Villa P, et al; Writing group of As. Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: the AGATA study. Maturitas 2016;83:40–44.
Gupta K, Hooton TM, Roberts PL, et al. Patient-initiated treatment of uncomplicated recurrent urinary tract infections in young women. Ann Intern Med 2001;135(1):9–16.
Schaeffer AJ, Stuppy BA. Efficacy and safety of self-start therapy in women with recurrent urinary tract infections. J Urol 1999;161(1):207–211.
Suskind AM, Saigal CS, Hanley JM, et al. Incidence and management of uncomplicated recurrent urinary tract infections in a national sample of women in the United States. Urology 2016;90:50–55.
Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011;52(5):e103–e120.
Zatorski C, Zocchi M, Cosgrove SE, et al. A single center observational study on emergency department clinician non-adherence to clinical practice guidelines for treatment of uncomplicated urinary tract infections. BMC Infect Dis 2016;16(1):638.
Kobayashi M, Shapiro DJ, Hersh AL, et al. Outpatient antibiotic prescribing practices for uncomplicated urinary tract infection in women in the United States, 2002–2011. Open Forum Infect Dis 2016;3(3):ofw159.
Food and Drug Administration. FDA Drug Safety Communication: FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling side effects that can occur together. 2016. Available at: https://www.fda.gov/Drugs/DrugSafety/ucm500143.htm. Accessed January 18, 2019.
Food and Drug Administration. FDA updates warnings for fluoroquinolone antibiotics on risks of mental health and low blood sugar adverse reactions. 2018. Available at: https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm612995.htm. Accessed January 18, 2019.